Medicare Advantage COVID Treatment Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Medicare Advantage COVID Treatment Act
This bill requires Medicare Advantage (MA) plans to cover specified treatment services relating to COVID-19 (i.e., coronavirus disease 2019) without cost-sharing during the public health emergency declared on January 31, 2020. The CMS must reimburse MA plans for cost-sharing amounts that would otherwise have been received, in accordance with a specified timeline.
MA plans are also prohibited from instituting prior authorization or other utilization management requirements with respect to coverage of specified critical treatment services (e.g., ventilator services and intensive care unit services).
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 6640: Medicare Advantage COVID Treatment Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-6640/
"H.R. 6640: Medicare Advantage COVID Treatment Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-6640/.
H.R. 6640, 116th Cong. (2026), https://openamerica.io/bill/116-HR-6640/.
[H.R. 6640: Medicare Advantage COVID Treatment Act](https://openamerica.io/bill/116-HR-6640/)